Polymyalgia Rheumatica Trial, Recruiting NCT06609668 Sponsor: Centre Hospitalier Universitaire Dijon Condition: Polymyalgia Rheumatica
Back to Polymyalgia Rheumatica

Polymyalgia Rheumatica Trial, Recruiting

NCT06609668
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have agreed to take part and given your verbal consent
  • You are over 50 years old
  • You were over 50 years old when your symptoms first started
  • You have pain and inflammation around the shoulders and/or hips (the large joints connecting your limbs to your body)
  • Your blood tests show signs of inflammation (raised ESR above 20 mm/hr and/or raised CRP above 10 mg/l)
  • You score 4 or more points from the following: morning stiffness lasting more than 45 minutes (2 points), hip pain or reduced hip movement (1 point), certain arthritis-related blood tests (rheumatoid factor and anti-CCP) coming back negative (2 points), and no pain in other joints (1 point)

Who may not be able to join:

  • You are not covered by national health insurance
  • You are under a legal protection order such as curatorship or guardianship
  • You are subject to any other form of legal safeguard (confirm with trial site)
  • You are pregnant or currently breastfeeding
  • You are unable to give your own consent to participate
  • You have received steroid or immune-suppressing treatment in the month before joining the trial
  • You have a medical reason why you cannot take steroid treatment
  • You currently have an active infection, cancer, or another inflammatory or autoimmune condition
  • You have a form of rheumatoid arthritis that started later in life
  • You have an allergy to iodine or significant kidney problems (if a CT scan with dye is needed for your imaging)
  • You have poorly controlled diabetes (if a PET scan is needed for your imaging)
  • Your final diagnosis turns out to be a cancer-related form of this condition
  • Your final diagnosis turns out to be rheumatoid arthritis
  • Your PET scan result comes back negative, if it was done within 72 hours of starting steroid treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0380293745

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire Dijon
Registry
ClinicalTrials.gov
Start date
10 October 2024
Est. completion
1 October 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Measurement of serum thrombomodulin concentrations by Luminex at diagnosis (prior to any glucocorticoid treatment)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov